SCHEMBL1735194

SCHEMBL1735194

O=C1c2cccc(F)c2C(=O)N1c1cccc(N2C(=O)c3cccc(F)c3C2=O)c1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HSPA1A P0DMV8 1/20 0.53
PABPC1 P11940 1/20 0.53
GRM1 Q13255 2/20 0.49
TYMS P04818 1/20 0.49
GRM4 Q14833 1/20 0.46
NR1H3 Q13133 1/20 0.46
ALPL P05186 1/20 0.46
PGR P06401 1/20 0.46
SCN2A Q99250 1/20 0.45
ADORA2A P29274 1/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44
ESR1 P03372 1/20 0.44
ALDH1A1 P00352 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4319648 0.89 HSPA1A (0.67) HSPA1APABPC1GRM1TYMSGRM4
SCHEMBL1736349 0.89 HSPA1A (0.56) HSPA1APABPC1GRM1GRM4ALPL
SCHEMBL9468815 0.80 HSPA1A (0.80) HSPA1APABPC1TYMSNR1H3SCN2A
SCHEMBL9241571 0.79 BRD4 (0.56) HSPA1APABPC1GRM1GRM4NR1H3
SCHEMBL1736347 0.79 HSPA1A (0.53) HSPA1APABPC1GRM1TYMSGRM4
SCHEMBL725608 0.78 NR1H3 (0.67) HSPA1APABPC1NR1H3SCN2ANPC1
SCHEMBL2890258 0.76 HSPA1A (0.54) HSPA1APABPC1TYMSNR1H3PGR
SCHEMBL19834886 0.76 DPP4 (0.55) GRM1GRM4ALPLADORA2A
SCHEMBL29631855 0.76 GRM1 (0.47) HSPA1APABPC1GRM1GRM4ALPL
SCHEMBL11845327 0.75 CTDSP1 (0.67) HSPA1APABPC1TYMSNR1H3SCN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2102160-B1 CARBAZOLYL MONOMERS AND POLYMERS GEN ELECTRIC (US) 2011-11-16 EP disclosed
US-20110262920-A1 METHODS FOR PREDICTING SURVIVAL IN CANCER PATIENTS CITY OF HOPE 2011-10-27 US disclosed
EP-2102159-B1 BIS-CARBAZOLE MONOMERS AND POLYMERS GEN ELECTRIC (US) 2011-06-22 EP disclosed
US-7851579-B2 Monomers comprising carbazole units and polymers, dendrimers, and hyper-branched materials derived therefrom; OLEDs having device quantum efficiencies, while still maintaining the potential for the molecules to host red, green, and blue emissive complexes GENERAL ELECTRIC COMPANY (US) 2010-12-14 US disclosed
US-7635777-B2 Carbazolyl monomers and polymers GENERAL ELECTRIC COMPANY (US) 2009-12-22 US disclosed
US-20080145665-A1 polyesters, polyethers, polycarbonates, polyestercarbonates, polyetherketones, or polyethersulfones for use in organic light emitters; quantum efficiencies GENERAL ELECTRIC COMPANY (US) 2008-06-19 US disclosed
US-20080138625-A1 CARBAZOLYL MONOMERS AND POLYMERS GENERAL ELECTRIC COMPANY (US) 2008-06-12 US disclosed
US-20080135806-A1 CARBAZOLYL POLYMERS FOR ORGANIC ELECTRONIC DEVICES GENERAL ELECTRIC COMPANY (US) 2008-06-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080138625-A1 CARBAZOLYL MONOMERS AND POLYMERS CBR3, C1S, C3AR1 HSPA1A 4531/4885PABPC1 2834/4885GRM1 2588/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.